Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.

by Birgit Engesæter, Olav Engebraaten, Vivi Ann Flørenes, Gunhild Mari Mælandsmo
Published 2012-01-01

Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.

by Nirma Skrbo, Geir-Olav Hjortland, Alexandr Kristian, Ruth Holm, Silje Nord, Lina Prasmickaite, Olav Engebraaten, Gunhild M Mælandsmo, Therese Sørlie, Kristin Andersen
Published 2014-01-01

Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer

by Kristi Krüger, Laxmi Silwal-Pandit, Elisabeth Wik, Oddbjørn Straume, Ingunn M. Stefansson, Elin Borgen, Øystein Garred, Bjørn Naume, Olav Engebraaten, Lars A. Akslen
Published 2021-02-01

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer

by Evita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, Kristine Kleivi Sahlberg, Vessela N. Kristensen, Daniel Nebdal, Anne‐Lise Børresen‐Dale, Ole Christian Lingjærde, Olav Engebraaten
Published 2019-10-01

Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen

by Anna Barkovskaya, Craig M. Goodwin, Kotryna Seip, Bylgja Hilmarsdottir, Solveig Pettersen, Clint Stalnecker, Olav Engebraaten, Eirikur Briem, Channing J. Der, Siver A. Moestue, Thorarinn Gudjonsson, Gunhild M. Mælandsmo, Lina Prasmickaite
Published 2021-08-01

Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab

by Shakila Jabeen, Manuela Zucknick, Marianne Nome, Ruth Dannenfelser, Thomas Fleischer, Surendra Kumar, Torben Lüders, Hedda von der Lippe Gythfeldt, Olga Troyanskaya, Jon Amund Kyte, Anne-Lise Børresen-Dale, Bjørn Naume, Xavier Tekpli, Olav Engebraaten, Vessela Kristensen
Published 2018-11-01

Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics

by Shakila Jabeen, Jaime A. Espinoza, Lilly Anne Torland, Manuela Zucknick, Surendra Kumar, Vilde D. Haakensen, Torben Lüders, Olav Engebraaten, Anne-Lise Børresen-Dale, Jon Amund Kyte, Pavel Gromov, Bjørn Naume, Vessela Kristensen, Irina Gromova, Xavier Tekpli
Published 2019-02-01

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations

by Elen Kristine Höglander, Silje Nord, David C. Wedge, Ole Christian Lingjærde, Laxmi Silwal-Pandit, Hedda vdL Gythfeldt, Hans Kristian Moen Vollan, Thomas Fleischer, Marit Krohn, Ellen Schlitchting, Elin Borgen, Øystein Garred, Marit M. Holmen, Erik Wist, Bjørn Naume, Peter Van Loo, Anne-Lise Børresen-Dale, Olav Engebraaten, Vessela Kristensen
Published 2018-11-01